{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dry-eye-syndrome/background-information/causes/","result":{"pageContext":{"chapter":{"id":"66b0cb58-895d-580a-bbe5-5e162cecbef6","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field 97aeb250-89bc-47b2-be9e-0ecccf139280 --><h2>What causes it?</h2><!-- end field 97aeb250-89bc-47b2-be9e-0ecccf139280 -->","summary":"","htmlStringContent":"<!-- begin item a295450b-cde6-4c96-9078-901087740f9f --><!-- begin field 915cd508-bb65-4bff-a856-f05f3879229a --><p><strong>Symptoms of dry eye can be due to:</strong></p><ul><li><strong>Meibomian gland dysfunction</strong> — secretion of lipids from the Meibomian ducts can be obstructed by cell debris and hardened meibomian lipids.</li><li><strong>Blepharitis</strong> — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/blepharitis/\">Blepharitis</a>.</li><li><strong>Age-related lacrimal gland deficiency</strong>.</li><li><strong>Low blink rate</strong> for example with computer screen use, reading or Parkinson’s disease.</li><li><strong>Vitamin A deficiency</strong>.</li><li><strong>Malposition of the eyelids</strong>, for example, lagophthalmos (inability to fully close the lid aperture), lid retraction, or proptosis.</li><li><strong>Environmental causes</strong> such as low relative humidity, high wind velocity, and allergens.</li><li><strong>Iatrogenic factors</strong> such as:<ul><li>Contact lens wear.</li><li>Medications such as retinoids, topical ophthalmic medications (especially those containing preservatives, in particular, benzalkonium chloride), oral contraceptives, antihistamines, beta-blockers, anticholinergics, and some psychotropics.</li><li>Ocular surgery, in particular laser corneal refractive surgery.</li><li>Post-radiation fibrosis of the lacrimal gland.</li></ul></li><li><strong>Underlying conditions</strong> such as:<ul><li>Primary or secondary Sjogren’s syndrome:<ul><li>Primary – autoimmune inflammation and destruction of lacrimal and salivary glands.</li><li>Secondary – associated with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis.</li></ul></li><li>HIV.</li><li>Sarcoidosis.</li><li>Allergic conjunctivitis.</li><li>Trachoma.</li><li>Endocrine disorders such as diabetes mellitus, thyroid disease, and androgen deficiency.</li><li>Menopause.</li><li>Dermatological disorders such as rosacea, Steven Johnson’s syndrome and mucous membrane pemphigus.</li><li>Haematological disorders including lymphoma and leukaemia.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">College of Optometrists, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">NICE, 2015a</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Messmer, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">BMJ Best Practice, 2016</a>]</p><!-- end field 915cd508-bb65-4bff-a856-f05f3879229a --><!-- end item a295450b-cde6-4c96-9078-901087740f9f -->","topic":{"id":"386fd023-80c8-5773-9545-27347387cc3b","topicId":"19fd4567-edfc-4646-8106-bd391e9fc519","topicName":"Dry eye syndrome","slug":"dry-eye-syndrome","lastRevised":"Last revised in August 2017","chapters":[{"id":"82582060-8b99-5c66-9fef-320feddcfce7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"4d65393d-c49d-5d93-97eb-529b725441ec","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"fdb881a7-0683-51f6-bf90-e722245af767","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0c07d88f-cc23-5753-8b62-acea5a2111b8","slug":"changes","fullItemName":"Changes"},{"id":"9590a4e4-d362-599d-b9b5-f38d9282b1d0","slug":"update","fullItemName":"Update"}]},{"id":"dfd74917-3fbf-5b2b-9def-21fcdbfd6143","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"54ce9280-6602-5b59-9353-0f274bb0b830","slug":"goals","fullItemName":"Goals"},{"id":"1b6213cb-be33-529a-ad0b-b254fa0e8f36","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6febc8d3-da2c-5312-b77b-a81a02506f5f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"58e7562c-bc9e-50f5-bc0b-04965c0355ac","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"232a2da6-5403-5f0d-8a60-6f2f0c4ea0ae","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ba9792a1-acb9-5b96-b150-e23871600eb9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a9ef0321-8ab7-5348-9b6b-c66ff0b06158","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8cf72d58-fb99-5b60-84d3-24b79f1d7464","slug":"definition","fullItemName":"Definition"},{"id":"66b0cb58-895d-580a-bbe5-5e162cecbef6","slug":"causes","fullItemName":"Causes"},{"id":"34c2a996-2361-578e-9016-983d6557b01f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1cb59582-b6a7-52c5-afe8-b83bad40c0c3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"70544490-0068-5332-ae85-3e602aa5ed38","slug":"complications","fullItemName":"Complications"}]},{"id":"65ed7852-6bae-5308-97f4-d5c274ff7161","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e0075104-686c-5823-8eb6-d07250f57544","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"42d15621-838d-5965-a184-63b4dcec2552","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"f1e7b678-059a-551d-9f3f-cdfb2881cedf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42d69539-0332-50ba-91b1-30550bdb1bc8","fullItemName":"Management","slug":"management","subChapters":[{"id":"0e301945-844e-5133-a1fa-498e54c17213","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8ecdaf09-c71f-5c15-b953-0b250cd5705e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7f2c12fa-faad-58ab-998a-3c58cd44f955","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a446bbd9-eb6d-5a79-9cab-321b94492137","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a9551351-ae9f-52e3-9fd8-b19d329a12ac","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"25984af0-631e-5b5e-8366-c2a6a53ffce8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2db358b8-f9a6-5529-8314-857008167af9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c6d15bc0-1daf-5ba8-80b8-d08bbbb68018","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5294e757-85ba-5226-8535-c8bd7ba1a467","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a9ef0321-8ab7-5348-9b6b-c66ff0b06158","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}